NovoCure Ltd (NVCR) › Gross ProfitNovoCure Ltd (NVCR) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2013: $3.35M2014: $5.45M2015: $12.48M2016: $36.61M2017: $121.42M2018: $168.02M2019: $262.71M2020: $387.87M2021: $420.15M2022: $422.97M2023: $381.06M2024: $468.04M2025: $488.47M$488.47M2013Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$488.47M+4.4%2024$468.04M+22.8%2023$381.06M-9.9%2022$422.97M+0.7%2021$420.15M+8.3%2020$387.87M+47.6%2019$262.71M+56.4%2018$168.02M+38.4%2017$121.42M+231.7%2016$36.61M+193.4%2015$12.48M+128.8%2014$5.45M+63.0%2013$3.35M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share